Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This week symbols : Sny save search
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
Published: 2024-04-25 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
MORF | $27.69 -3.69% -3.68% 330K
|
Health Technology
| Email alert
Add to watchlist
first for financial results
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Published: 2024-04-25 (Crawled : 11:00) - globenewswire.com
REGN | News | $906.54 -0.09% -0.08% 280K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
for
Merck Announces First-Quarter 2024 Financial Results
Published: 2024-04-25 (Crawled : 11:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
| Email alert
Add to watchlist
GILD | $67.08 0.08% 0.06% 2.5K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
MRK | $127.0 0.1% 0.63% 5.7M
|
Health Technology
| Email alert
Add to watchlist
ELAN | $13.31 -1.11% 0.0% 0
|
Process Industries
| Email alert
Add to watchlist
merck financial results
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
Published: 2024-04-25 (Crawled : 08:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
sales
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
Published: 2024-04-25 (Crawled : 06:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
sales sanofi growth
Dassault Systèmes Reports Solid First Quarter Results And Reaffirms Full-Year Objectives
Published: 2024-04-25 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
first results
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Published: 2024-04-25 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
| Email alert
Add to watchlist
asco meeting
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.09% 4.2M
|
Health Technology
|
| O: -0.82%
H: 0.37%
C: 0.17%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -1.91%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
rare first opioid approval for
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published: 2024-04-24 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.3K
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: 1.21%
business
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
LTRN | News | $5.38 -6.76% -6.07% 98K
|
Health Technology
|
| O: 1.21%
H: 2.91%
C: -7.88%
pharma drug key leaders development
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K
|
Health Technology
|
| O: -0.05%
H: 0.97%
C: -0.04%
asco tumors treatment blood for
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
car-t sanofi
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.3K
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: 1.21%
BNTX | News | $88.09 -0.45% -0.35% 1.9K
|
Health Technology
|
| O: 0.11%
H: 0.97%
C: -0.56%
business update for financial results
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
RLYB | News | $1.58 -9.2% -9.43% 250K
|
|
| O: -3.05%
H: 0.0%
C: -9.71%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M
|
Health Technology
|
| O: -1.94%
H: 0.0%
C: -6.58%
TXMD | News | $1.92 2.13% -0.27% 15K
|
Health Technology
|
| O: 0.53%
H: 2.12%
C: 1.59%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K
|
Health Technology
|
| O: -0.71%
H: 0.81%
C: -2.25%
NKTR | News | $1.38 -2.82% -2.16% 960K
|
Health Technology
|
| O: -1.08%
H: 3.65%
C: 0.73%
MOR | News | $18.05 0.06% 0.17% 130K
|
Health Technology
|
| O: 0.0%
H: 0.28%
C: 0.06%
GLPG | News | $28.77 -2.31% -2.33% 1.5K
|
Health Technology
|
| O: 0.48%
H: 0.17%
C: -1.88%
AMRN | News | $0.8786 -0.53% 0.12% 2.6K
|
Health Technology
|
| O: 0.57%
H: 1.14%
C: 0.0%
GOOGL | News 4 | $159.13 0.55% 0.58% 290K
|
Technology Services
|
| O: 0.29%
H: 1.31%
C: 1.04%
GOOG | News 4 | $161.1 0.74% 0.7% 180K
|
Technology Services
|
| O: 0.32%
H: 1.45%
C: 1.26%
OCX | News | $2.46 0.2% -6.74% 40K
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: -1.99%
biopharma
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
RLYB | News | $1.58 -9.2% -9.43% 250K
|
|
| O: -3.05%
H: 0.0%
C: -9.71%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M
|
Health Technology
|
| O: -1.94%
H: 0.0%
C: -6.58%
TXMD | News | $1.92 2.13% -0.27% 15K
|
Health Technology
|
| O: 0.53%
H: 2.12%
C: 1.59%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K
|
Health Technology
|
| O: -0.71%
H: 0.81%
C: -2.25%
NKTR | News | $1.38 -2.82% -2.16% 960K
|
Health Technology
|
| O: -1.08%
H: 3.65%
C: 0.73%
MOR | News | $18.05 0.06% 0.17% 130K
|
Health Technology
|
| O: 0.0%
H: 0.28%
C: 0.06%
GLPG | News | $28.77 -2.31% -2.33% 1.5K
|
Health Technology
|
| O: 0.48%
H: 0.17%
C: -1.88%
AMRN | News | $0.8786 -0.53% 0.12% 2.6K
|
Health Technology
|
| O: 0.57%
H: 1.14%
C: 0.0%
GOOGL | News 4 | $159.13 0.55% 0.58% 290K
|
Technology Services
|
| O: 0.29%
H: 1.31%
C: 1.04%
GOOG | News 4 | $161.1 0.74% 0.7% 180K
|
Technology Services
|
| O: 0.32%
H: 1.45%
C: 1.26%
OCX | News | $2.46 0.2% -6.74% 40K
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: -1.99%
biopharma
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
first drug authorized food depression treatment clearance for therapeutics
Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
RLYB | News | $1.58 -9.2% -9.43% 250K
|
|
| O: 1.98%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: 0.0%
TXMD | News | $1.92 2.13% -0.27% 15K
|
Health Technology
|
| O: -0.53%
H: 1.07%
C: 0.53%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
NKTR | News | $1.38 -2.82% -2.16% 960K
|
Health Technology
|
| O: 1.84%
H: 0.0%
C: 0.0%
MOR | News | $18.05 0.06% 0.17% 130K
|
Health Technology
|
| O: 0.39%
H: 0.0%
C: 0.0%
GLPG | News | $28.77 -2.31% -2.33% 1.5K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
AMRN | News | $0.8786 -0.53% 0.12% 2.6K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GOOGL | News 4 | $159.13 0.55% 0.58% 290K
|
Technology Services
|
| O: 0.48%
H: 0.0%
C: 0.0%
GOOG | News 4 | $161.1 0.74% 0.7% 180K
|
Technology Services
|
| O: 0.41%
H: 0.0%
C: 0.0%
OCX | News | $2.46 0.2% -6.74% 40K
|
Health Technology
|
| O: -1.99%
H: 0.0%
C: 0.0%
biopharma sanofi
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
drug candidate treatment for trial response
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.13%
H: 1.89%
C: 1.3%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.09% 4.2M
|
Health Technology
|
| O: 0.56%
H: 0.41%
C: -0.07%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
fda bladder cancer treatment
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.